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Abstract
Background: There have been many randomized controlled trials of screening and brief alcohol
intervention in primary care. Most trials have reported positive effects of brief intervention, in
terms of reduced alcohol consumption in excessive drinkers. Despite this considerable evidence-
base, key questions remain unanswered including: the applicability of the evidence to routine
practice; the most efficient strategy for screening patients; and the required intensity of brief
intervention in primary care. This pragmatic factorial trial, with cluster randomization of practices,
will evaluate the effectiveness and cost-effectiveness of different models of screening to identify
hazardous and harmful drinkers in primary care and different intensities of brief intervention to
reduce excessive drinking in primary care patients.
Methods and design: GPs and nurses from 24 practices across the North East (n = 12), London
and South East (n = 12) of England will be recruited. Practices will be randomly allocated to one of
three intervention conditions: a leaflet-only control group (n = 8); brief structured advice (n = 8);
and brief lifestyle counselling (n = 8). To test the relative effectiveness of different screening
methods all practices will also be randomised to either a universal or targeted screening approach
and to use either a modified single item (M-SASQ) or FAST screening tool. Screening
randomisation will incorporate stratification by geographical area and intervention condition.
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During the intervention stage of the trial, practices in each of the three arms will recruit at least 31
hazardous or harmful drinkers who will receive a short baseline assessment followed by brief
intervention. Thus there will be a minimum of 744 patients recruited into the trial.
Discussion: The trial will evaluate the impact of screening and brief alcohol intervention in routine
practice; thus its findings will be highly relevant to clinicians working in primary care in the UK.
There will be an intention to treat analysis of study outcomes at 6 and 12 months after intervention.
Analyses will include patient measures (screening result, weekly alcohol consumption, alcohol-
related problems, public service use and quality of life) and implementation measures from practice
staff (the acceptability and feasibility of different models of brief intervention.) We will also examine
organisational factors associated with successful implementation.
Trial registration: Current Controlled Trials ISRCTN06145674.
Background
Epidemiological data have shown that the majority of
alcohol-related problems in a population are not due to
individuals with significant alcohol dependence, but to a
much larger group of hazardous and harmful drinkers [1].
Hazardous drinking increases the risk of physical or psy-
chological problems whilst harmful drinking is defined
by the presence of these symptoms. In the UK, hazardous
and harmful drinkers outnumber dependent drinkers by a
ratio of 7:1 [1]. Thus it clear that the greatest impact in
reducing alcohol-related problems at a population level
can be made by reducing alcohol consumption in hazard-
ous and harmful drinkers, rather than by focusing on the
most extreme cases of alcohol dependence; this is known
as the preventive paradox [2].
Screening and brief alcohol intervention is an example of
secondary preventive care [3]. It aims to identify hazard-
ous or harmful drinking at an early stage, before people
are consciously aware of (or seeking help for) problems,
and then provide advice or counselling to help reduce
consumption levels. Primary care is an ideal setting for
such activity as this is most people's first point of contact
with health services. In addition, primary care deals with
a wide range of conditions and aims to prevent as well as
treat disease [4]. In the UK, two-thirds of the population
visit their GP one or more times each year and 90% attend
at least once every five years [5]. In primary care, alcohol
screening in routinely presenting cases has shown that
one in five patients were drinking at hazardous or harmful
levels [6,7]. These patients were consulting GPs and
nurses about a wide range of health problems and not
about alcohol per se. Thus the large proportion of patients
with alcohol-related risk or harm, and the general lack of
awareness about the impact of heavy drinking on health,
means there is a great potential for screening and brief
intervention to help reduce alcohol-related problems in
primary care.
Current evidence on screening and brief intervention
There is a strong evidence-base supporting the effective-
ness of brief intervention at reducing alcohol consump-
tion in adults who are not seeking treatment for alcohol-
related problems. Numerous systematic reviews and
meta-analyses have reported beneficial outcomes of brief
intervention, compared to control conditions, in terms of
reductions in hazardous and harmful drinking [8-17]. The
most recent review of brief interventions in primary care
was a Cochrane Collaboration review which included 29
randomized controlled trials of brief alcohol intervention
in primary care. This work reported a significant reduction
in weekly drinking at one-year follow-up compared to a
range of control conditions (such as assessment only,
treatment as usual and written information) [17]. The
magnitude of this effect was an average reduction of 4–5
standard drinks per week.
Despite the large number of trials in this area, there have
been key challenges to the evidence on brief interventions
concerning its relevance to routine practice in primary
care and its relevance to different types of drinkers. It has
been reported that much of the published evidence on
brief alcohol intervention has consisted of efficacy trials
[18], conducted in tightly controlled research conditions
designed to optimize internal validity [19]. Efficacy stud-
ies are important in 'proof of concept' contexts where new
or early stage treatments are considered. However, if clini-
cians are to deliver interventions in routine practice, it is
necessary to establish that they are effective in clinically
relevant contexts. Secondly, its has been observed that
participants in brief intervention trials may not be repre-
sentative of the whole population; the research to date has
focused heavily on Caucasian males who are middle-aged
and has under-represented minority groups, women and
young people [17,20].
In addition, there are key gaps in the evidence-base
regarding the cost-effectiveness of brief interventions, theBMC Public Health 2009, 9:287 http://www.biomedcentral.com/1471-2458/9/287
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efficiency of screening activity and the ideal format of
brief intervention. Regarding the cost-effectiveness of
screening and brief intervention in primary care, one US
study has reported cost-savings from brief alcohol inter-
vention four years after the intervention was delivered
[21]. However, it is necessary to establish if similar cost-
savings can be found in different research trials and differ-
ent country contexts. Also, despite the fact that the vast
majority of trials in this field have involved screening to
identify patients who require brief intervention, the effi-
ciency and acceptability of screening has been questioned
[22,23]. In particular, doubts have been expressed about
the strategy of screening all patients (universal screening)
and it has been suggested that clinicians should only
screen patients with a high likelihood of alcohol-related
problems [24]. However, such targeted screening has not
been evaluated in terms of either its effectiveness or effi-
ciency in primary care. Lastly, although brief intervention
can result in positive changes in excessive drinking, it is
not clear if simple structured advice is sufficient for all
hazardous and harmful drinkers or if motivationally
enhanced counselling provides significant additional ben-
efit to some individuals. The most recent review of brief
alcohol intervention found no significant additional ben-
efit of longer compared to shorter brief interventions [17].
However, this meta-regression analysis focused on the
length of time clinicians spent delivering brief interven-
tion to patients and not the content of the brief interven-
tion sessions. Simple, structured advice may take less time
to deliver and involve less preparatory training but it may
also have less impact than motivationally-enhanced
counselling. Thus there is a clear need for both an impact
and cost-effectiveness analysis of differing intensities of
brief alcohol intervention.
In summary, there is a need for more pragmatic research
in this field to ensure that the work adequately represents
the reality of routine primary care. It is also necessary to
ensure that the research trial is located in areas with suffi-
cient diversity to adequately reflect the population of a
country. There is a need to evaluate, not just the effective-
ness of brief intervention but also its cost-effectiveness at
reducing alcohol-related risk and harm. Finally, there is a
need to establish the most efficient means of screening
patients in primary care so as to minimise the workload
for busy clinicians whilst also ensuring that appropriate
patients receive brief intervention.
Aims of the study
To identify the most efficient and acceptable screening
approach and tool to detect cases of hazardous and harm-
ful drinking in routine primary care and also to evaluate
the clinical impact and cost effectiveness of different mod-
els of BI aimed at reducing excessive drinking in routine
primary health care.
Objectives
￿ To conduct a pragmatic multicentre cluster ran-
domised controlled trial of screening and brief inter-
vention for hazardous and harmful drinkers in
primary care in three English regions.
￿ To identify the optimal method and tool for alcohol
screening in routine primary care.
￿ To compare the effectiveness and cost effectiveness
of different models of brief intervention with a control
condition in patients with hazardous and harmful
alcohol consumption.
￿ To assess the uptake and use (implementation) of
different screening and brief intervention approaches
by clinicians in routine primary care.
￿ To identify attitudinal, practical, skill, resource, and
reinforcing factors that may predict successful imple-
mentation of screening and brief intervention in pri-
mary care.
￿ To assess the relative impact of the different models
of screening and brief intervention on uptake of alco-
hol services, including an alcohol helpline.
Methods and design
Setting
GPs and primary care nurses from 24 practices in three
English regions (North East: n = 12, London & South East:
n = 12) will be recruited to take part in the study. All pri-
mary care practices delivering general medical services in
the three regions that do not have current routine screen-
ing and brief intervention facilities will be eligible to par-
ticipate. The study catchment area enables broad
population coverage and randomization procedures will
ensure that practices cover a range of urban and rural
areas, socially deprived and affluent communities, tradi-
tional communities with relatively stable populations and
more urbanized fluid populations, and culturally mixed
populations.
Design
The trial has a 2 × 2 × 3 nested factorial design encompass-
ing screening approach (targeted versus universal screen-
ing), screening method (the Fast Alcohol Screening Test
(FAST) [25] or a modified Single Alcohol Screening Ques-
tionnaire (M-SASQ)) [26]) and brief intervention inten-
sity (Patient information leaflet (PIL); Brief advice (BA);
Brief lifestyle counselling (BLC)). The main advantages of
utilising a factorial approach are twofold. First each of the
three elements (screening approach, screening tool and
intervention) can be analysed independently with suffi-
cient power to make meaningful interpretation of relativeBMC Public Health 2009, 9:287 http://www.biomedcentral.com/1471-2458/9/287
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effectiveness. Second, the method enables meaningful
interpretations of the relative effectiveness of any combi-
nation of screening approach, screening tool and inter-
vention modality.
We will recruit 24 general practices from the North East,
London and the South East of England. Practices will be
randomly assigned to 1 of 2 screening approaches (12
practices in each approach), 1 of 2 screening tools (12
practices using each tool) and 1 of 3 intervention condi-
tions (8 practices in each condition) as shown in Table 1.
Since we expect that there may be a difference in uptake of
screening between intervention conditions, we expect the
recruitment to take varying periods of time in the different
conditions.
The trial will incorporate cluster randomisation of prac-
tices to avoid the risk of contamination. Clinicians trained
to deliver 'talk-based' advice or counselling become com-
promised in their ability to deliver alternative versions of
such care; thus it is not practical for individual clinicians
to deliver both control and intervention conditions in this
trial. Therefore clinicians will consistently deliver a partic-
ular version of brief intervention. Cluster randomisation
also provides an opportunity to pragmatically evaluate
brief interventions in primary care in a way that will allow
issues of implementation to be addressed from a practice
perspective.
Study Hypotheses
￿ Targeted screening methods will result in greater
implementation of screening activity than longer
more broadly focused (universal) approaches.
￿ Motivationally-enhanced brief intervention for haz-
ardous and harmful drinkers will be more effective
than advice or written information, as follows: BLC >
BA > PIL.
￿ Brief intervention (either advice or counselling) will
be more cost effective than merely providing a patient
information leaflet.
￿ Attitudinal, practical, skill, resource, and reinforcing
factors will predict screening and brief intervention
activity.
Practice recruitment
Contact with practices will initially be via telephone since
this was found to be the most cost-effective method of
promoting brief intervention activity in primary care
[27,28]. Thereafter a practice visit will be arranged to ena-
ble research staff to explain the trial protocol, secure clini-
cian consent to participate in the study and to organise the
practice-based training.
Inclusion criteria
Practices
All practices delivering general medical services who have
not already instigated screening and brief intervention
systems.
Patients
Any patient with a positive screening result on FAST or M-
SASQ, who is alert and orientated, aged 18 or over, resi-
dent within 20 miles, and able to speak, read and write
English sufficiently well to complete study question-
naires.
Exclusion criteria
Patients already involved in an alcohol research study and
those seeking help for alcohol problems will be excluded.
Any patients who are severely injured, suffering from seri-
ous mental health problem and/or are grossly intoxicated
will also be excluded from the study. Finally patients with
no fixed abode will be excluded from the study.
Randomisation
Randomisation will be conducted using a secure remote
randomisation service. Twenty four allocations will be
generated for each of the possible factorial combinations
of screening approach (Targeted versus Universal), screen-
ing tool (FAST vs M-SASQ) and intervention (PIL vs BA vs
BLC). Practices and allocations will be randomly sampled
without replacement and paired to generate allocation
Table 1: SIPS Primary Care trial design
Intervention condition North London & the South East
Screening condition Leaflet Brief Advice Brief Counselling Leaflet Brief Advice Brief Counselling Totals
Targeted presentation FAST 31 31 31 31 31 31 186 (6)
M-SASQ 31 31 31 31 31 31 186 (6)
Universal presentation FAST 31 31 31 31 31 31 186 (6)
M-SASQ 31 31 31 31 31 31 186 (6)
Number of patients per intervention 124 124 124 124 124 124 744
Number of practices per intervention 4 4 4 4 4 4 24BMC Public Health 2009, 9:287 http://www.biomedcentral.com/1471-2458/9/287
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groups. The randomisation will be stratified by geograph-
ical area (north versus south).
Screening
In order to test the relative acceptability and effectiveness
of different screening methods in identifying hazardous
and harmful drinkers, we intend to conduct a nested com-
parison, within our trial, of universal versus targeted
screening approaches and of two short screening tools,
FAST [25] versus M-SASQ. We were aware from our pilot
work that shorter screening instruments are more likely to
be adopted in the typical primary care setting than the
longer AUDIT. However, it is unclear which tool is most
effective in identifying cases of hazardous and harmful
drinking in routine primary care settings.
FAST has undergone validity testing in primary care and
has been found to be of high sensitivity and specificity
[25] and performs well in comparison to the currently rec-
ognized 'gold standard', the Alcohol Use Disorders Iden-
tification Test or AUDIT [29].
The original SASQ was validated in the USA and asked
'When was the last time you had more than X drinks in
one day?' where X = 4 for women and 5 for men [26]. A
response of 'monthly', 'weekly' or 'daily or almost daily' is
considered a positive screen (1 drink = unit of alcohol).
The original values of X were based on US standard drink
containing 12 g of alcohol [30]. Since a UK standard drink
contains 8 g of alcohol, the equivalent cut-off points in
the UK are X = 6 for women and 8 for men. Because SASQ
is derived from the third question of AUDIT, we decided
to modify the wording so that it accorded with AUDIT
since the latter is the key outcome measure in the trial.
Hence, the modified M-SASQ asked "How often do you
have X or more standard drinks on one occasion?" where
X = 6 for women and 8 for men. We validated M-SASQ in
pilot work and found that it had a higher sensitivity and
specificity than the original SASQ when compared to the
AUDIT [29].
Practices will be randomly assigned to either screen all
presenting patients (universal screening) or to screen
patients presenting with specific linked conditions (tar-
geted screening): hypertension, mental health problems,
gastrointestinal problems, injuries and new patient regis-
trations. Within each screening approach, practices will be
randomly assigned to use either FAST or M-SASQ. Thus we
will have 12 practices in each of the two screening
approaches group and 12 practices in each of the two
screening tool groups.
Within the universal screening condition, clinicians will
record the reason for the presentation in all the patients
they screen. Thus we will be able to empirically identify
the most common presenting conditions for patients with
alcohol-related problems. We will also compare the effi-
cacy of targeted versus universal screening in successfully
identifying and providing interventions for the relevant
target population. Lastly we will compare the relative effi-
cacy of the two screening tools, and combinations of
screening methods and tools, in identifying and deliver-
ing alcohol interventions to the relevant target population
by considering recruitment rates between screening arms
of the trial.
In all conditions, the research team will support partici-
pating practices in implementing screening systems tai-
lored to the needs of the practice.
Consent
Consent to participate will be obtained in a 2-stage proc-
ess. Primary care staff will initially establish verbal con-
sent to check eligibility to take part, collect some basic
demographic information and to be screened. No identi-
fiable information will be collected at this stage. Patients
who then are positive on FAST or M-ASQ, as applicable,
will have the study explained to them verbally by primary
care staff and in writing (using the patient information
sheet). Written informed consent will be obtained at this
stage which will include permission to give the patient's
data and contact details to the research staff, provide the
research team with access to the patients' records, and par-
ticipate in follow up after 6 and 12 months. The research
team will then contact the patient within two weeks to
thank him/her to take part in the study.
Interventions
Patient Information Leaflet
In the eight practices randomised to the control condi-
tion, participating staff will be trained to screen eligible
patients for hazardous or harmful drinking. Patients who
screen positive and provide consent to participate in the
study will complete the baseline questionnaire and then
be provided with a patient information leaflet (PIL) http:/
/www.sips.iop.kcl.ac.uk. The PIL to be used in this trial is
the Department of Health's 'How much is too much?
Drinking and you' which contains details of the Drinkline
telephone number where the patient can access further
information including treatment options for alcohol
problems. A sticker with local alcohol services will also be
attached to the back cover.
Brief advice condition
In the eight practices randomized to deliver Brief Advice,
participating staff will be trained to screen eligible
patients for hazardous or harmful drinking. Patients who
screen positive and provide consent to participate in the
study will complete the baseline questionnaire and will
then receive up to five minutes of simple structured briefBMC Public Health 2009, 9:287 http://www.biomedcentral.com/1471-2458/9/287
Page 6 of 13
(page number not for citation purposes)
advice from trained staff, using the SIPS Brief Advice tool
"Brief advice about alcohol risk" which has been devel-
oped for the SIPS programme. It is based on the "How
much is too much? Simple Structured Advice intervention
tool, developed as part of the UK version of the Drink-Less
BI programme [31] from a prototype used as part of a
World Health Organisation collaborative study on alco-
hol screening and brief. Patients in this condition will also
receive a Patient Information Leaflet (PIL) at the end of
the brief advice.
Brief lifestyle counselling
In the eight practices randomized to deliver Brief Lifestyle
Counseling, participating staff will be trained to screen eli-
gible patients for hazardous or harmful drinking. Patients
who screen positive and provide consent to participate in
the study will complete the baseline questionnaire and
will then receive up to five minutes of simple structured
brief advice from trained ED staff, using the SIPS Brief
Advice tool "Brief advice about alcohol risk". Patients in
this condition will also receive a Patient Information Leaf-
let (PIL) at the end of the brief advice. Practice staff will
also be trained to deliver a 20 minute brief lifestyle coun-
seling intervention to patients who attend for a subse-
quent appointment at the practice. The SIPS Brief Lifestyle
Counselling (BLC) Tool is based on the "How much is too
much?" extended Brief Intervention tool developed as
part of the UK version of the Drink-Less BI programme
[31] from a prototype used as part of a World Health
Organisation collaborative study on alcohol screening
and brief intervention.
All intervention tools and protocols are available from the
SIPS study website http://www.sips.iop.kcl.ac.uk.
Training and Support
All primary care staff participating in the trial will be
trained to implement alcohol screening and brief inter-
vention according to the trial protocol. The aim of the
training is to provide some background information
about alcohol related harm, to give an overview of the
study protocol, to familiarise staff with the screening
tools, structure and scoring procedures, and to inform
staff about the procedure for implementing screening and
brief intervention at their site. Given the cluster design of
the trial, staff will only be introduced to the screening tool
and brief intervention condition they have been ran-
domly allocated to. The training is individualised accord-
ing to the implementation procedure agreed with the
local collaborator and senior colleagues in the practice.
A substantial element of the training will involve the
understanding of and familiarisation with alcohol units
to ensure that the practitioners are fully aware of the alco-
hol content of different alcoholic drinks so they are able
to complete the screening tools accurately. Moreover, as
the screening tools refer to standard drinks rather than
units when assessing consumption, the training will
ensure that staff are aware that a standard drink is one unit
and that they are able to convert different drinks into the
number of standard drinks e.g. one pint of premium lager
equals three standard drinks (or three units). Visual repre-
sentations of standard drinks as well as several examples
of people's drinking patterns will be used to allow trainees
to practice calculating units in each drink and to add up
the number of standard drinks/alcohol units consumed in
order to identify positive cases.
Training of staff to deliver brief advice
Participating primary care staff will receive a one hour
training session on how to deliver five minutes of brief
advice according to the protocol. The aim of the training
will be to provide practitioners with the skills necessary to
effectively and empathically deliver brief advice about
alcohol risk to patients in their practice. The training was
developed by the SIPS team to be delivered by an Alcohol
Health Worker (AHW). The AHWs in the SIPS team are
experienced practitioners in the field of alcohol treatment.
They contributed to the development of the training pack-
age and have been fully trained to deliver the training to
practitioners. The training package is based on a Power-
Point presentation with scripts to standardise delivery.
The training sessions are adapted for use in the different
experimental conditions in which BA is being delivered.
The session will be presented to small groups of clinicians
who will be encouraged to interact with the trainer, ask
questions and comment on the content. This will be fol-
lowed by interactive role play in which the AHW demon-
strates the intervention and each practitioner then has an
opportunity to practice with a co-worker, observed by the
trainer who provides feedback and encouragement. We
envisage that training sessions will be delivered to groups
of 1–10 practitioners with 3–4 being the typical group
size.
Training of staff to deliver brief lifestyle counselling
Primary care staff who are suitable to deliver brief lifestyle
counselling will receive formal training and supervision
on Brief Lifestyle Counselling, in addition to the Brief
Advice training. The training will be based upon the pre-
vious work of Rollnick et al. [32] in addition to experi-
ences from an earlier trial of screening and brief
interventions [33]. The training will comprise four main
elements: orientation to the relevant practice, standard-
ised PowerPoint presentation, tape recorded simulated
consultations with trained actors and ongoing clinical
supervision provided by experienced AHWs.
The simulated consultations will be recorded and rated by
three independent clinical assessors. The practitioner will
be assessed for adherence to the BLC protocol in additionBMC Public Health 2009, 9:287 http://www.biomedcentral.com/1471-2458/9/287
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to their behaviour and skills using the Behaviour Change
Counselling Index (BECCI) [34]. Assessors will submit
BECCI ratings, comments and supervision points for each
consultation. This information will support clinical super-
vision and training until the practitioner reaches a
required standard of practice agreed by an independent
clinical assessor.
Support regarding the paperwork for the research will be
provided by a research team member, who will also act as
the site study coordinator. Research staff and trainers will
maintain regular contact with practices throughout the
study period, including site visits and telephone support.
Outcome Measures
Staff attitudinal and organisational measures
Participating staff in practices will be surveyed before and
after training in each condition of the study to assess atti-
tudinal factors and factors influencing implementation of
screening and brief intervention procedures.
Attitudes will be assessed via the shortened Alcohol and
Alcohol Problems Perception Questionnaire (SAAPPQ)
[35]. A list of all professional staff that can deliver alcohol
screening and brief intervention in each study site will be
compiled. A self-administered SAAPPQ will be distributed
to participating staff on three occasions: pre-training,
post-training and post-study. SAAPPQ has five subscales
covering role adequacy, role legitimacy, self-esteem, moti-
vation, and work satisfaction. Role adequacy and role
legitimacy are concerned with role security, i.e., how indi-
viduals perceive the adequacy of their skills and knowl-
edge in relation to problem drinkers and how appropriate
it is for them to work with such clients. The subscales
relating to self esteem, motivation and work satisfaction,
are concerned with worker's therapeutic commitment,
i.e., the extent to which they seek to engage drinkers in
treatment and the extent that they find the work reward-
ing on both a professional or personal level [36].
In addition to the SAAPPQ, the post-training and post-
study questionnaires will contain a number of semi-struc-
tured and open questions developed to elicit information
on staff attitudes towards alcohol screening and brief
intervention; previous experience of delivering alcohol
screening and brief intervention; readiness to undertake
these activities; the training needed to conduct screening
and brief intervention; the suitability of each site to pro-
vide SBI; and potential barriers to effective implementa-
tion.
Factors relevant to implementation of screening and brief
intervention have been found to be divided into predispos-
ing, enabling and reinforcing factors [37]. Predisposing fac-
tors relate to clinicians' willingness to implement
screening and brief intervention. Enabling factors are the
skills and resources needed to implement screening and
brief intervention. Reinforcing factors are visible results,
feedback from peers and patients and other factors that
encourage continuation of screening and brief interven-
tion.
In the USA, Babor et al. [37] collected data on these factors
in two ways: (1) surveys of providers and specialists com-
pleted prior to training, after training and at the end of
project operations (five items) and (2) independent rat-
ings of site factors made by two research staff during regu-
lar technical assistance contacts and site visits (17 items).
Inter-rater reliability in Babor et al. [37] was high for all
factors (median r = 0.70).
In the USA study, predisposing factors were: (1) peer
approval for alcohol screening; (2) organizational
approval for alcohol screening; (3) the frequency clini-
cians asked about alcohol consumption; (4) the fre-
quency clinicians educated patients about health risks; (5)
the frequency clinicians advised patients with problem
drinking to cut down or stop drinking; (6) stable patient
membership was based on researcher ratings of whether
patient membership was stable or changing; and (7)
organisational instability based on ratings of fiscal and
management stability. Enabling factors were derived from
ratings conducted by two research staff. These factors
were: (8) number of clinicians trained at each clinic; (9)
doctors' time; (10) nurses' time, (11) receptionists' time;
(12) doctors' turnover; (13) nurses' turnover; (14) recep-
tionists' turnover; (15) competing organizational priori-
ties; (16) having an influential site coordinator; (17)
involvement of clinic staff in planning; (18) facilitation
by computer technology; (19) amount of technical assist-
ance; and (20) successful procedural changes. Two factors
classified as reinforcing implementation were also derived
from the research staff ratings: (21) organisational sup-
port; and (22) financial incentives. An average organiza-
tional score was created based on the sum of the 17 items
the two researchers rated. This score indicated the total
extent of favourable predisposing, enabling and reinforc-
ing factors observed at a given clinic.
In this study we will survey primary care staff before and
after training and compare the above factors between dif-
ferent implementation models.
System measures
The research team will identify the total number of
patients aged over 18 years who attended the practices
during the recruitment period, the total number of
patients screened, the number screening positive and the
number receiving an alcohol intervention in each of the 3
implementation models. This will allow calculation of theBMC Public Health 2009, 9:287 http://www.biomedcentral.com/1471-2458/9/287
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overall screening rate, the screen conversion rate (propor-
tion of positive screens) and the intervention rate in the
different settings. We will also compare these measures
between practices assigned to universal versus targeted
screening and the FAST versus M-SASQ screening tools.
Patient re-attendances at practices over the 6 and 12
month follow-up periods will be assessed using compu-
terised records and compared with attendances by partic-
ipating patients in the 12 months before entry into the
study. The sustainability of the screening and intervention
approaches will be assessed by examining the extent to
which screening and intervention activity continues after
the end of the formal study recruitment period.
Patient measures
A summary of the measures used with patients and the
stage that they are administered are summarised in Figure
1.
Baseline
Immediately before receiving the initial PIL and/or brief
advice intervention, participants will be invited by the pri-
mary care staff to provide contact details and complete the
Extended AUDIT[29], Euroqol (EQ-5D) [38], a short serv-
ice use questionnaire (S-SUQ) [39] and modified Readi-
ness Ruler [40]. Participants in the extended intervention
will complete the baseline at the same stage as those in
other groups.
AUDIT is normally used as a screening test for alcohol use
disorders [29]. However in this context the AUDIT will be
used as a means of establishing the severity of alcohol use
disorders at baseline, in a way that is least intrusive to nat-
uralistic aim of the trial in the primary care setting and as
a means of measuring the adequacy of matching between
the intervention groups at baseline. The AUDIT contains
10 items to measure alcohol consumption, alcohol prob-
lems and dependence over, in this case, the previous 6
months, and the sum of the item scores provides a meas-
ure of severity which has been used in several previous
studies, allowing comparability with other primary care
samples [1]. We felt that the use of more elaborate base-
line alcohol consumption measures would interfere with
the naturalistic aims of the study and possibly would con-
tribute a form of intervention in itself, so introducing bias
into the evaluation of the interventions by reducing the
difference between trial interventions. In addition, partic-
ipants will complete the EQ-5D as a brief 5-item measure
of quality of life [38]. Use of health, social criminal justice
services and wider societal costs will be measured via a
shortened version of Service Use Questionnaire [39]
which allows estimation of health care and wider social
costs for health economic analysis in the six months prior
to intervention. A modified Readiness Ruler [40] contain-
ing a zero to ten scale of the extent to which participants
think about their drinking as a problem or have addressed
this issue will assess participants' motivational state
regarding changing their drinking behaviour.
Follow-up
At 6 and 12 months after intervention, all patients will be
contacted via telephone or post as preferred by research
staff who will be blind to their intervention condition.
Patients will be offered telephone, postal or face-to-face
follow-up as preferred. Researchers will administer the
shorter Alcohol Use Disorders Identification Test
(Extended-AUDIT) [41]. Alcohol-related problems will be
assessed via the brief Alcohol Problems Questionnaire
(APQ) [42]. We will also re-administer an extended ver-
sion of the Service Use Questionnaire SUQ [39], EQ-5D
[38]. Patient satisfaction with the advice/help received
during the intervention will be assessed using a modified
version of the Patient Satisfaction Questionnaire (short
form) at 12 months [43].
At follow-up, each patient will also be asked if, and how
often, they made use of the Drink-Line telephone
number.
All intervention tools and protocols are available from the
SIPS study website http://www.sips.iop.kcl.ac.uk.
Financial incentives
Research causes significant disruption to busy practices as
well as occupying additional clinical time (consent,
assessment, training, data collection procedures etc.). Cli-
nicians are unlikely to participate in a research trial with-
out incentivisation [44] and retention of practices in the
trial may also be at risk [45]. However, in this pragmatic
trial we were cognisant of the need to evaluate interven-
tions in such a way as to reflect routine primary care. Pay-
ing clinicians pro rata for clinical behaviour could
undermine our ability to assess implementation out-
comes on the basis of acceptability of screening and brief
intervention models or how well these have embedded in
practice systems. Thus we separated incentives into pay-
ment for research participation and for clinical activity.
We will incentivise research participation via the payment
of £3,000 to each practice, subject to successful patient
recruitment. Payments will be staged, with £1,000 paid at
the outset after taking part in the training, £1,000 paid on
completion of successful recruitment of participants and
£1,000 paid at end of data collection. We hope this sched-
ule of payments will ensure that practices will remain in
the trial throughout the study period. A minimum thresh-
old is set of recruiting 31 cases per practice, which would
entail screening at least 155 patients per practice since
20% of patients in primary care are likely to be hazardousBMC Public Health 2009, 9:287 http://www.biomedcentral.com/1471-2458/9/287
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Measures used with patients and the stage that they are administered Figure 1
Measures used with patients and the stage that they are administered.
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or harmful drinkers [6]. This will cover the time and dis-
ruption caused by participating in the research study.
However, practices may stop at this minimum case
number.
We will also incentivise screening and brief intervention
clinical activity as if this was part of the Quality and Out-
comes Framework (QOF) in core general medical services
(GMS). We will model the payment on smoking cessation
work in the Quality Outcomes Framework (QoF) where
points are awarded for building a register of cases and for
delivering advice (in 2005, 1 point = £125). At this time,
in the coronary heart disease area of QOF, GPs gained 6
points for building a case register (£750) and 10 points for
a specific percentage of cases receiving advice (£1,250).
We will use practice-level figures (from PCT commission-
ing colleagues) to scale payments to a per patient fee
accordingly (See Table 2).
Participant incentives
Each patient participant will receive a £10 voucher,
together with a Thank You letter in the post shortly after
completing the baseline research questionnaires and
another £10 voucher for completing the 6 and 12 month
research follow-up interview.
Economic evaluation
The economic component of the study will consist of a
cost-effectiveness and cost-utility analysis. The study aims
to identify, quantify and value resources related to alcohol
SBI by clinicians in primary care and the subsequent use
of health, social care and criminal justice services by
patients following each type of intervention.
Resources utilised in the identification and brief interven-
tion delivery or control condition will be recorded by
practice staff involved on an ongoing basis. This will allow
the calculation of costs of implementation of different
models of screening and brief intervention. Local values
will be used to calculate the costs of the interventions,
which will include staff costs, premises costs and costs of
leaflets and other consumables. In addition, specific train-
ing costs for staff will be calculated, in terms of staff time,
premises costs and the cost of training materials.
Patients' use of health, social care and criminal justice
services will be identified retrospectively using a short
SUQ and applying a common set of national unit cost
estimates. Patient costs in the 6 month period before SBI
can then be compared to cost in the 6 month period after
SBI to explore any changes in costs imposed by patients in
each group.
The economic analysis will calculate the incremental cost-
effectiveness of the control condition with each of the
screening and brief intervention conditions under study,
using measures of clinical outcome and quality of life
responses at 6 and 12 month follow-ups. The use of EQ-
5D enables the estimation of Quality Adjusted Life Years
(QALYs). Data will be bootstrapped to account for the
expected skewness evident in economic cost data [46].
The analysis will include the construction of cost-effec-
tiveness acceptability curves to illustrate the probability
that the brief intervention is more cost-effective than
usual care, based on different monetary values being
attached to QALYs. The use of QALYs follows the recom-
mendations of NICE [47] and enables the value for
money afforded by treatment to be compared to a range
of other health care interventions. Furthermore, combina-
tion of the economic cost data and outcome data with
patient data collected in the trial will enable a secondary
analysis of various patient characteristics that may influ-
ence the cost-effectiveness of the intervention.
Table 2: Incentives for screening and brief intervention activity
Average practice list size 5,500
Number of eligible adults in the practice 2,250
We assumed 1/3 adults screened 750 cases
Screening fee = 750/750 £1 per patient screened
We assuming 1/5 cases were screen positive 150 cases
Advice fee = 1,250/150 £8 per patient advised*
Counselling is four times longer than advice 31 cases required
Counselling fee £32 per patient counselled.
* This fee will also be given to control practices delivering the leaflet.BMC Public Health 2009, 9:287 http://www.biomedcentral.com/1471-2458/9/287
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Sample size calculation
The sample size calculation was designed to account pri-
marily for intervention level outcomes. Powering the
study in this way will also account statistically for appro-
priate outcomes for screening approach and screening
method. The primary outcome for this study is the pro-
portion of patients who consume alcohol within recom-
mended levels at 6 month follow up. A comprehensive
meta-analysis [13] suggested that the difference between
brief intervention and control is of the order 13%; that is
a 5% reduction in the control group and 18% in the brief
intervention group. Detecting a difference of this magni-
tude at the 5% significance level with 80% power, for a 2-
sided test, requires 109 patients in each of the 3 groups
and a total of 327. Our experience with other multi-centre
randomized controlled trials of interventions for alcohol
use disorders suggests that with assiduous follow-up the
potential loss to follow-up across groups is of the order
25%. Taking this loss into accounts inflates the sample
required to 145 in each group, a total of 435 patients.
The proposed study involves a cluster design and requires
a statistical adjustment to account for any potential cluster
effect. The literature, and our previous experience of trials
in primary care [44], suggest an intra-class correlation
coefficient of 0.04 is appropriate. Assuming a cluster size
of 31 patients inflated the sample size calculation by a fac-
tor of 1.7 requiring 248 patients in each group and a total
of 744, with an expectation that at least 558 will be fol-
lowed up at 12 months.
Planned analysis
As the study is pragmatic in design, the planned analysis
will be by intention to treat. The primary outcome (drink-
ing within or above recommended levels) is dichotomous
and so will be analysed with logistic regression adjusting
for all known prognostic factors; data will be presented as
odds ratios and their corresponding confidence intervals.
Secondary analyses will be undertaken using the appro-
priate method for the outcomes, controlling where appro-
priate for intake values and other known prognostic
variables using analysis of covariance. Due to the nested
factorial nature of the study, we will use multi-level mod-
elling to explore potential interactions between each of
the three levels nested within the trial (screening
approach, screening method and intervention). Practice
and patient factors will be utilised as part of regression
model to explore possible prognostic factors that impact
on outcome. Interaction analysis will explore any possible
interactions between practice and patient characteristics
and outcome. The efficacy of interventions will be
explored with a secondary analysis utilising a per protocol
approach; a sub-sample of patients who engaged in their
allocated treatment will be utilised in this analysis.
Ethical and Research Governance Approval
We have obtained Multi-centre ethical approval for the
trial (MREC reference number: 06/MRE02/90) plus local
agreement from all relevant LRECS. In addition, research
governance approval has been granted by all relevant pri-
mary care trusts.
Project Timescales
The trial duration is 30 months and it commenced in
April 2008.
Discussion
Whilst there is a great deal of evidence relating to screen-
ing and brief intervention for alcohol problems in pri-
mary care, much of this is of questionable relevant to
routine clinical practice. The proposed pragmatic trial will
provide evidence that will inform primary care practice in
both England and outside the UK. In addition to consid-
ering the effectiveness and cost-effectiveness of screening
and brief intervention at reducing alcohol consumption
and its related problems, the trial will also provide impor-
tant information about implementation issues which are
likely to influence future uptake and use of this secondary
preventive approach by primary care practitioners.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
This paper is published on behalf of the SIPS programme
research group. A full list of the research group members
is available at http://sips.iop.kcl.ac.uk/contactus.php. The
study is funded by the Department of Health. The views
expressed herein do not necessarily reflect those of the
Department of Health or the National Health Service in
England and Wales. All of the authors contributed to the
design and development of this trial protocol. CD is the
Chief Investigator of SIPS and EK is Deputy Chief Investi-
gator and lead for the Primary Care trial. Expertise on clin-
ical aspects of the research was provided for primary care
by PC and JM, for nursing practice by TP and for psychia-
try CD and EG. Statistical input was provided by SC and
MB. Health economics input was provided by CG and SP.
Trial conduct and delivery expertise was provided by PD,
DNB and KP. Alcohol and policy expertise was provided
by AO and DS. Brief intervention expertise was provided
by CD, EK, NH and JS. EK wrote the first draft of the paper
and all authors contributed to successive drafts. All
authors read and approved the final manuscript.
References
1. Drummond C, Oyefeso A, Phillips T, Cheeta S, Deluca P, Perryman
K, Winfield H, Jenner J, Cobain K, Galea S, et al.: Alcohol needs
assessment research project (ANARP). The 2004 nationalBMC Public Health 2009, 9:287 http://www.biomedcentral.com/1471-2458/9/287
Page 12 of 13
(page number not for citation purposes)
needs assessment for England.  London: Department of Health
and the National Treatment Agency; 2004. 
2. Kreitman N: Alcohol consumption and the preventive para-
dox.  British Journal of Addictions 1986, 81:353-363.
3. Winett RA: A framework for health promotion and disease
prevention programs.  American Psychologist 1995, 50(5):341-350.
4. Starfield B, Shi L, Macinko J: Contribution of primary care to
health systems and health.  The Millbank Quarterly 2005,
83(3):457-502.
5. Fraser RC: Setting the scene.  In Clinical Method: A General Practice
Approach 2nd edition. Edited by: Fraser RC. Oxford: Butterworth
Heinmann; 1992. 
6. Kaner E, Heather N, Brodie J, Lock C, McAvoy B: Patient and prac-
titioner characteristics predict brief alcohol intervention in
primary care.  British Journal of General Practice 2001, 51:822-827.
7. Lock C, Kaner E: Implementation of brief alcohol interven-
tions by nurses in primary care: do non-clinical factors influ-
ence practice?  Family Practice 2004, 21(3):270-275.
8. Agosti V: The efficacy of treatments in reducing alcohol con-
sumption: a meta-analysis.  International Journal of the Addictions
1995, 30(8):1067-1077.
9. Bien TH, Miller WR, Tonigan JS: Brief interventions for alcohol
problems: a review.  Addiction 1993, 88(3):315-335.
10. Freemantle N, Gill P, Godfrey C, Long A, Richards C, Sheldon T, Song
F, Webb J: Brief Interventions and Alcohol Use.  Effective Health
Care Bulletin 1993, 7:1-13.
11. Wilk AI, Jensen NM, Havinghurst TC: Meta-analysis of rand-
omized control trials addressing brief interventions in heavy
alcohol drinkers.  Journal of General Internal Medicine 1997,
12:274-283.
12. Poikolainen K: Effectiveness of brief interventions to reduce
alcohol intake in primary health care populations: a meta-
analysis.  Preventive Medicine 1999, 28:503-509.
13. Moyer A, Finney JW, Swearingen CE, Vergun P: Brief interventions
for alcohol problems: a meta-analytic review of controlled
investigations in treatment-seeking and non-treatment-
seeking populations.  Addiction 2002, 97(3):279-292.
14. Ballesteros JA, Duffy JC, Querejeta I, Arino J, Gonzalez-Pinto A: Effi-
cacy of brief interventions for hazardous drinkers in primary
care: systematic review and meta-analysis.  Alcoholism, Clinical
& Experimental Research 2004, 28(4):608-618.
15. Bertholet N, Daeppen J-B, Wietlisbach V, Fleming M, Burnand B:
Brief alcohol intervention in primary care: systematic review
and meta-analysis.  Archives of Internal Medicine 2005, 165:986-995.
16. Whitlock EP, Polen MR, Green CA, Orleans T, Klein J: Behavioral
counseling interventions in primary care to reduce risky/
harmful alcohol use by adults: a summary of the evidence for
the US Preventive Services Task Force.  Annals of Internal Med-
icine 2004, 140:557-568.
17. Kaner E, Beyer F, Dickinson H, Pienaar E, Campbell F, Schlesinger C,
Heather N, Saunders J, Burnand B: Effectiveness of brief alcohol
interventions in primary care populations.  Cochrane Database
of Systematic Reviews 2007:CD004148. DOI:004110.001002/
14651858.CD14654148.pub14651853
18. Babor TF, Higgins-Biddle JC, Dauser D, Burleson JA, Zarkin GA, Bray
J: Brief interventions for at-risk drinking: patient outcomes
and cost-effectiveness in managed care organizations.  Alcohol
& Alcoholism 2006, 41(6):624-631.
19. Flay BR: Efficacy and effectiveness trials (and other phases of
research) in the development of health promotion pro-
grams.  Preventive Medicine 1986, 15:451-474.
20. Edwards AGK, Rollnick S: Outcome studies of brief alcohol
intervention in general practice: the problem of lost sub-
jects.  Addiction 1997, 92(12):1699-1704.
21. Fleming MF, Mundt MP, French MT, Manwell LB, Stauffacher EA, Barry
KL: Benefit-cost analysis of brief physician advice with prob-
lem drinkers in primary care settings.  Medical Care 2000,
38(1):7-18.
22. Beich A, Thorsen T, Rollnick S: Screening in brief intervention
trials targeting excessive drinkers in general practice: sys-
tematic review and meta-analysis.  British Medical Journal 2003,
327(7414):536-540.
23. Beich A, Gannick D, Malterud K: Screening and brief interven-
tion for excessive alcohol use: qualitative interview study of
the experiences of general practitioners.  British Medical Journal
2002, 325(7369):870-872.
24. Prime Minister's Strategy Unit: Alcohol Harm Reduction Strat-
egy for England.  London: Cabinet Office; 2004. 
25. Hodgson R, Alwyn T, John B, Thom B, Smith A: The FAST alcohol
screening test.  Alcohol & Alcoholism 2002, 37(1):61-66.
26. Canagasaby A, Vinson DC: Screening for hazardous or harmful
drinking using one or two quantity-frequency questions.  Alco-
hol & Alcoholism 2005, 40(3):208-213.
27. Lock CA, Kaner EFS, Heather N, McAvoy BR, Gilvarry E: A ran-
domised trial of three marketing strategies to disseminate a
screening and brief alcohol intervention programme to gen-
eral practitioners.  British Journal of General Practice 1999,
49:695-698.
28. Lock CA, Kaner EFS: Use of marketing to disseminate brief
alcohol intervention to general practitioners: promoting
health interventions to health promoters.  Journal of Evaluation
in Clinical Practice 2000, 6(4):345-357.
29. Saunders JB, Aasland OG, Babor TF, De La Fuente JR, Grant M:
Development of the Alcohol Use Disorders Identification
Test (AUDIT): WHO Collaborative Project on Early Detec-
tion of Persons with Harmful Alcohol Consumption.  Addiction
1993, 88(6):791-804.
30. Miller W, Heather N, Hall W: Calculating standard drink units:
international comparisons.  British Journal of Addiction 1991,
86:43-47.
31. Heather N, Girvan M, Kaner E, Cassidy P: Implementing screen-
ing and brief alcohol intervention in pilot general practices in
the Tyne and Wear Health Action Zone (Final report).  In A
final report on research funded by the Tyne and Wear Health Action Zone
Newcastle upon Tyne: Northumbria University; 2008. 
32. Rollnick S, Butler C, McCambridge J, Kinnersley P, Elwyn G: Consul-
tations about changing behaviour.  British Medical Journal 2005,
331:961-963.
33. Drummond D, James D, Coulton S, Parrott S, Baxter J, Ford D, God-
frey C, Lervy B, Peters T, Russell I, et al.: The effectiveness and
cost-effectiveness of screening and stepped-care interven-
tions for alcohol use disorders in the primary care setting.  In
Final report to the Welsh Office for Research and Development Cardiff:
Wales Office for Research and Development; 2004. 
34. Lane C: The Behaviour Change Counselling Index (BECCI)
Scale.  Cardiff: University of Wales; 2002. 
35. Anderson P, Clement S: The AAPPQ revisited: The measure-
ment of general practitioners attitudes to alcohol problems.
British Journal of Addiction 1987, 82:753-759.
36. Gorman DM, Cartwright AKJ: Implications of using the compos-
ite and short versions of the Alcohol and Alcohol Problems
Perception Questionnaire (AAPPQ).  British Journal of Addiction
1991, 86:327-334.
37. Babor TE, Higgins-Biddle J, Dauser D, Higgins P, Burleson JA: Alco-
hol screening and brief intervention in primary care settings:
implementation models and predictors.  Journal of Studies on
Alcohol 2005, 66(3):361-368.
38. Rabin R, Charro F: EQ-5D: a measure of health status from the
euroqol group.  Annals of Medicine 2001, 33(5):337-343.
39. UKATT Research Team: Cost effectiveness of treatment for
alcohol problems: findings of the randomised UK alcohol
treatment trial (UKATT).  British Medical Journal 2005,
331(7516):544.
40. Heather N, Smailes D, Cassidy P: Development of a Readiness
Ruler for use with alcohol brief interventions.  Drug and Alcohol
Dependence 2008, 98:235-240.
41. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA: The
AUDIT alcohol consumption questions (AUDIT-C): an effec-
tive brief screening test for problem drinking.  Archive of Inter-
nal Medicine 1998, 158:1789-1795.
42. Drummond DC: The relationship between alcohol depend-
ence and alcohol-related problems in a clinical population.
British Journal of Addiction 1990, 85:357-366.
43. Ware J, Snyder M, Wright W, (Eds): Development and validation of
scales to measure patient satisfaction with medical care services Springfield
VA: National Technical Information Service; 1976. 
44. Drummond C, Coulton S, James D, Godfrey C, Parrott S, Baxter J,
Ford D, Lervy B, Rollnick S, Russell I, et al.: Pilot study of the effec-
tiveness and cost-effectiveness of stepped care intervention
for alcohol use disorders in primary care – STEPWICE trial.
British Journal of Psychiatry 2009 in press.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Public Health 2009, 9:287 http://www.biomedcentral.com/1471-2458/9/287
Page 13 of 13
(page number not for citation purposes)
45. Lock C, Kaner E, Heather N, Purdy S, McNamee P, Doughty J, Craw-
shaw A, Pearson P: Effectiveness of nurse-led brief alcohol
intervention: A cluster randomised controlled trial.  Journal of
Advanced Nursing 2005, 54(4):426-439.
46. National Institute for Clinical Excellence: Guide to the methods of tech-
nology appraisal. Volume National primary care development team: North-
ern NPDT Centre London: National Institute for Clinical Excellence;
2004. 
47. Briggs A, Gray A: Handling uncertainty when performing eco-
nomic evaluation of health care interventions.  Health Technol-
ogy Assessment 1999, 3(2):.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2458/9/287/pre
pub